Title: Guideline: Management of community-acquired pneumonia in adults
Abstract: Objective: To revise the existing South African community-acquired pneumonia guideline in the light of the following factors: •� Increasingantibioticresistance •� Introductionofnewantibiotics •� Internationaltrendsbasedonevidencepublishedsincethe� previous guideline. •� Themainaimoftheguidelineistorecommendaninitialchoice� of antibiotics in patients with community-acquired pneumonia encompassing the following subgroups: - Adults without co-morbid illness - The elderly and/or those with associated co-morbid illness, including patients with concomitant human immunodeficiency virus (HIV) infection - Patients with severe pneumonia Options: Studies comparing patient outcome obtained with the various treatment regimens have been reviewed. The choice of antibiotic is based on the most commonly isolated pathogens, with cost as a consideration. Outcomes: The empiric antibiotic therapy covers all commonly encountered organisms in patients with community-acquired pneumonia and is likely to achieve the best prognosis. Evidence: Working group of clinicians and clinical microbiologists, following detailed literature review, particularly of studies performed in South Africa. Benefits, harms and costs: The guideline pays particular attention to cost-effectiveness in South Africa and promotes rational antibiotic prescribing with the aim of limiting emergence of antibiotic resistance.
Publication Year: 2008
Publication Date: 2008-01-01
Language: en
Type: article
Access and Citation
Cited By Count: 1
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot